Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.

Abstract : Fragment-based drug discovery has become a powerful method for the generation of drug leads against therapeutic targets. Beyond the identification of novel and effective starting points for drug design, fragments have emerged as reliable tools for assessing protein druggability and identifying protein hot spots. Here, we have examined fragments resulting from the deconstruction of known inhibitors from the glycogen phosphorylase enzyme, a therapeutic target against type 2 diabetes, with two motivations. First, we have analyzed the fragment binding to the multiple binding sites of the glycogen phosphorylase, and then we have investigated the use of fragments to study allosteric enzymes. The work we report illustrates the power of fragmentlike ligands not only for probing the various binding pockets of proteins, but also for uncovering cooperativity between these various binding sites.
Type de document :
Article dans une revue
Journal of Medicinal Chemistry, American Chemical Society, 2012, 55 (3), pp.1287-95. 〈10.1021/jm201439b〉
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-00691495
Contributeur : Frédérique Depierre <>
Soumis le : jeudi 26 avril 2012 - 13:50:00
Dernière modification le : mercredi 12 décembre 2018 - 15:27:41

Identifiants

Collections

Citation

Isabelle Krimm, Jean-Marc Lancelin, Jean-Pierre Praly. Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.. Journal of Medicinal Chemistry, American Chemical Society, 2012, 55 (3), pp.1287-95. 〈10.1021/jm201439b〉. 〈hal-00691495〉

Partager

Métriques

Consultations de la notice

203